Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
87.14 CHF | +0.55% | +0.61% | +2.80% |
Mar. 25 | NOVARTIS AG : Berenberg remains Neutral | ZD |
Mar. 22 | Swiss Equities Ends Central Bank Week in the Red; Galderma Shines on Debut | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.80% | 210B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+1.02% | 210B | |
-6.63% | 201B | |
-3.51% | 157B | |
-0.60% | 153B |
- Stock
- Equities
- Stock Novartis AG - Swiss Exchange
- News Novartis AG
- Novartis : to Test COVID-19 Treatment Candidate in Phase 2/3 Study